JOURNAL ARTICLES 2021, NOVEL THERAPEUTIC AGENTS
Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer Domínguez-Jurado E, Cimas FJ, Castro-Osma JA, Juan A, Lara-Sánchez A, Rodríguez-Diéguez A, Shafir A, Ocaña A, Alonso-Moreno C....
JOURNAL ARTICLES 2022, NOVEL THERAPEUTIC AGENTS
Clinical considerations for the design of PROTACs in cancer Nieto-Jiménez C, Morafraile EC, Alonso-Moreno C, Ocaña A. Mol Cancer. 2022 Mar 7;21(1):67. PMID: 35249548; PMCID: PMC8900451. doi: 10.1186/s12943-022-01535-7...
JOURNAL ARTICLES 2022, NOVEL THERAPEUTIC AGENTS
A bis(pyrazolyl)methane derivative against clinical Staphylococcus aureus strains isolated from otitis externa Ocaña AV, Aguilera-Correa JJ, Domínguez-Jurado E, Pérez-Martínez FC, Pérez-Tanoira R, López-Carretero Y, Masiá-Mondejar J, Castro-Osma JA, Esteban J,...
JOURNAL ARTICLES 2019, NOVEL THERAPEUTIC AGENTS
Screening and Preliminary Biochemical and Biological Studies of [RuCl(p-cymene)(N, N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer Models Corrales Sánchez V, Nieto-Jiménez C, Castro-Osma JA, de Andrés F, Pacheco-Liñán PJ, Bravo I, Rodríguez Fariñas...
JOURNAL ARTICLES 2021, NOVEL THERAPEUTIC AGENTS
New titanocene derivative with improved stability and binding ability to albumin exhibits high anticancer activity Serrano R, Martinez-Argudo I, Fernandez-Sanchez M, Pacheco-Liñan PJ, Bravo I, Cohen B, Calero R, Ruiz MJ. J Inorg Biochem. 2021 Oct;223:111562. Epub...
JOURNAL ARTICLES 2023, NOVEL THERAPEUTIC AGENTS
Synthesis, characterization, and antibacterial activities of a heteroscorpionate derivative platinum complex against methicillin-resistant Staphylococcus aureus Nam-Cha SH, Domínguez-Jurado E, Tinoco-Valencia SL, Pérez-Tanoira R, Morata-Moreno N, Alfaro-Ruiza R,...